A detailed history of Rhenman & Partners Asset Management Ab transactions in Elevance Health, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 50,500 shares of ELV stock, worth $19.9 Million. This represents 2.19% of its overall portfolio holdings.

Number of Shares
50,500
Previous 85,800 41.14%
Holding current value
$19.9 Million
Previous $46.5 Million 43.52%
% of portfolio
2.19%
Previous 4.59%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$500.12 - $562.29 $17.7 Million - $19.8 Million
-35,300 Reduced 41.14%
50,500 $26.3 Million
Q2 2024

Aug 13, 2024

BUY
$497.49 - $547.8 $8.11 Million - $8.93 Million
16,300 Added 23.45%
85,800 $46.5 Million
Q1 2024

May 14, 2024

BUY
$464.61 - $519.96 $26.3 Million - $29.4 Million
56,500 Added 434.62%
69,500 $36 Million
Q4 2023

Feb 13, 2024

SELL
$433.51 - $488.06 $10.8 Million - $12.2 Million
-25,000 Reduced 65.79%
13,000 $6.13 Million
Q3 2023

Nov 13, 2023

SELL
$414.13 - $475.93 $44.3 Million - $50.9 Million
-107,000 Reduced 73.79%
38,000 $16.5 Million
Q3 2023

Nov 09, 2023

BUY
$414.13 - $475.93 $36.9 Million - $42.4 Million
89,000 Added 158.93%
145,000 $63.1 Million
Q1 2023

May 11, 2023

BUY
$446.3 - $502.2 $4.91 Million - $5.52 Million
11,000 Added 24.44%
56,000 $25.7 Million
Q4 2022

Feb 13, 2023

BUY
$465.23 - $546.77 $2.33 Million - $2.73 Million
5,000 Added 12.5%
45,000 $23.1 Million
Q3 2022

Nov 14, 2022

SELL
$445.98 - $507.0 $7.58 Million - $8.62 Million
-17,000 Reduced 29.82%
40,000 $21.9 Million
Q2 2022

Aug 12, 2022

BUY
$444.32 - $529.84 $4.8 Million - $5.72 Million
10,801 Added 23.38%
57,000 $27.5 Million
Q1 2022

May 13, 2022

SELL
$428.44 - $502.48 $22.2 Million - $26 Million
-51,801 Reduced 52.86%
46,199 $22.7 Million
Q4 2021

Feb 11, 2022

SELL
$370.08 - $467.67 $8.14 Million - $10.3 Million
-22,000 Reduced 18.33%
98,000 $45.8 Million
Q3 2021

Nov 12, 2021

BUY
$357.51 - $398.13 $8.94 Million - $9.95 Million
25,000 Added 26.32%
120,000 $44.7 Million
Q1 2021

May 14, 2021

BUY
$287.7 - $371.31 $4.32 Million - $5.57 Million
15,000 Added 18.75%
95,000 $34.1 Million
Q4 2020

Jan 19, 2021

SELL
$270.17 - $333.15 $2.7 Million - $3.33 Million
-10,000 Reduced 11.11%
80,000 $25.7 Million
Q3 2020

Oct 13, 2020

BUY
$245.73 - $284.63 $6.14 Million - $7.12 Million
25,000 Added 38.46%
90,000 $24.2 Million
Q1 2020

Apr 16, 2020

BUY
$174.68 - $307.74 $524,040 - $923,220
3,000 Added 4.84%
65,000 $14.8 Million
Q4 2019

Jan 17, 2020

BUY
$234.82 - $306.42 $469,640 - $612,840
2,000 Added 3.33%
62,000 $18.7 Million
Q3 2019

Oct 16, 2019

SELL
$237.69 - $310.48 $7.13 Million - $9.31 Million
-30,000 Reduced 33.33%
60,000 $14.4 Million
Q2 2019

Jul 22, 2019

BUY
$236.25 - $293.76 $3.86 Million - $4.8 Million
16,355 Added 22.21%
90,000 $25.4 Million
Q1 2019

Apr 11, 2019

SELL
$248.42 - $317.42 $1.24 Million - $1.59 Million
-5,000 Reduced 6.36%
73,645 $21.1 Million
Q4 2018

Feb 05, 2019

BUY
$249.0 - $296.25 $2.15 Million - $2.56 Million
8,645 Added 12.35%
78,645 $20.7 Million
Q3 2018

Oct 03, 2018

SELL
$238.27 - $274.12 $1.43 Million - $1.64 Million
-6,000 Reduced 7.89%
70,000 $19.2 Million
Q2 2018

Jul 20, 2018

BUY
$220.13 - $245.16 $3.3 Million - $3.68 Million
15,000 Added 24.59%
76,000 $18.1 Million
Q1 2018

Apr 11, 2018

BUY
$215.63 - $258.19 $6.47 Million - $7.75 Million
30,000 Added 96.77%
61,000 $13.4 Million
Q4 2017

Jan 19, 2018

SELL
$183.76 - $234.96 $4.41 Million - $5.64 Million
-24,000 Reduced 43.64%
31,000 $6.98 Million
Q3 2017

Oct 13, 2017

BUY
$181.44 - $197.43 $9.98 Million - $10.9 Million
55,000
55,000 $10.4 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $94.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.